Maria A. Lopez Olivo, M.D., M.Sc., Ph.D.

Peer-Reviewed Articles

1. Chhatwal J, He T, Hur C, Lopez-Olivo MA. Direct-Acting Antiviral Agents for Patients With Hepatitis C Virus Genotype 1 Infection Are Cost-Saving. Clin Gastroenterol Hepatol 15(6):827-837.e8, 2017. e-Pub 2016. PMID: 27650326.
2. Siddhanamatha HR, Heung E, Lopez-Olivo MLA, Abdel-Wahab N, Ojeda-Prias A, Willcockson I, Leong A, Suarez-Almazor ME. Quality assessment of websites providing educational content for patients with rheumatoid arthritis. Semin Arthritis Rheum 46(6):715-723, 2017. e-Pub 2017. PMID: 28258768.
3. Zamora NV, Christensen R, Goel N, Klokker L, Lopez-Olivo MA, Kristensen LE, Carmona L, Strand V, Curtis JR, Suarez-Almazor ME. Critical Outcomes in Longitudinal Observational Studies and Registries in Patients with Rheumatoid Arthritis: An OMERACT Special Interest Group Report. J Rheumatol, 2017. e-Pub 2017. PMID: 28620065.
4. Pundole X, Cheema HI, Petitto GS, Lopez-Olivo MA, Suarez-Almazor ME, Lu H. Prevention and treatment of bone loss and fractures in patients undergoing a hematopoietic stem cell transplant: a systematic review and meta-analysis. Bone Marrow Transplant 52(5):663-670, 2017. e-Pub 2017. PMID: 28112742.
5. Lopez-Olivo MA, Ingleshwar A, Volk RJ, Jibaja-Weiss M, Barbo A, Saag K, Leong A, Suarez-Almazor ME. Development and Pilot Testing of Multimedia Patient Education Tools for Patients with Knee Osteoarthritis, Osteoporosis, and Rheumatoid Arthritis. Arthritis Care Res (Hoboken), 2017. e-Pub 2017. PMID: 28464546.
6. Pan X, Lopez-Olivo MA, Song J, Pratt G, Suarez-Almazor ME. Systematic review of the methodological quality of controlled trials evaluating Chinese herbal medicine in patients with rheumatoid arthritis. BMJ Open 7(3):e013242, 2017. e-Pub 2017. PMID: 28249848.
7. Singh JA, Hossain A, Tanjong Ghogomu E, Mudano AS, Maxwell LJ, Buchbinder R, Lopez-Olivo MA, Suarez-Almazor ME, Tugwell P, Wells GA. Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis. Cochrane Database Syst Rev 3:CD012591, 2017. e-Pub 2017. PMID: 28282491.
8. Abdel-Wahab N, Lopez-Olivo MA, Pinto-Patarroyo GP, Suarez-Almazor ME. Systematic review of case reports of antiphospholipid syndrome following infection. Lupus 25(14):1520-1531, 2016. e-Pub 2016. PMID: 27060064.
9. Bruera S, Barbo AG, Lopez-Olivo MA. Use of medication reminders in patients with rheumatoid arthritis. Rheumatol Int 36(11):1543-1548, 2016. e-Pub 2016. PMID: 27590013.
10. Volk RJ, Linder SK, Lopez-Olivo MA, Kamath GR, Reuland DS, Saraykar SS, Leal VB, Pignone MP. Patient Decision Aids for Colorectal Cancer Screening: A Systematic Review and Meta-analysis. Am J Prev Med 51(5):779-791, 2016. e-Pub 2016. PMID: 27593418.
11. Lethaby A, Lopez-Olivo MA, Maxwell L, Burls A, Tugwell P, Wells GA. Etanercept for the treatment of rheumatoid arthritis. Cochrane Database Syst Rev(5):CD004525, 2013. e-Pub 2013. PMID: 23728649.
12. Peddi P, Lopez-Olivo MA, Pratt GF, Suarez-Almazor ME. Denosumab in patients with cancer and skeletal metastases. Cancer Treat Rev 39(1):97-104, 2013. e-Pub 2012. PMID: 22898302.
13. Lopez-Olivo MA, Andrabi TR, Palla SL, Suarez-Almazor ME. Cervical spine radiographs in patients with rheumatoid arthritis undergoing anesthesia. J Clin Rheumatol 18(2):61-6, 2012. PMID: 22334269.
14. Lopez-Olivo MA, Landon GC, Siff SJ, Edelstein D, Pak C, Kallen MA, Stanley M, Zhang H, Robinson KC, Suarez-Almazor ME. Psychosocial determinants of outcomes in knee replacement. Ann Rheum Dis 70(10):1775-81, 2011. e-Pub 2011. PMID: 21791452.
15. Singh JA, Beg S, Lopez-Olivo MA. Tocilizumab for rheumatoid arthritis: a cochrane systematic review. J Rheumatol 38(1):10-20, 2011. e-Pub 2010. PMID: 20952462.
16. Pollono EN, Lopez-Olivo MA, Lopez JA, Suarez-Almazor ME. A systematic review of the effect of TNF-alpha antagonists on lipid profiles in patients with rheumatoid arthritis. Clin Rheumatol 29(9):947-55, 2010. e-Pub 2010. PMID: 20383550.
17. Singh JA, Beg S, Lopez-Olivo MA. Tocilizumab for rheumatoid arthritis. Cochrane Database Syst Rev 7(7):CD008331, 2010. e-Pub 2010. PMID: 20614469.
18. Singh JA, Christensen R, Wells GA, Suarez-Almazor ME, Buchbinder R, Lopez-Olivo MA, Ghogomu ET, Tugwell P. A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a cochrane overview. CMAJ 181(11):787-96, 2009. e-Pub 2009. PMID: 19884297.
19. Singh JA, Christensen R, Wells GA, Suarez-Almazor ME, Buchbinder R, Lopez-Olivo MA, Tanjong Ghogomu E, Tugwell P. Biologics for rheumatoid arthritis: an overview of Cochrane reviews. Cochrane Database Syst Rev(4):CD007848, 2009. e-Pub 2009. PMID: 19821440.
20. Maillefert JF, Kloppenburg M, Fernandes L, Punzi L, Günther KP, Martin Mola E, Lohmander LS, Pavelka K, Lopez-Olivo MA, Dougados M, Hawker GA. Multi-language translation and cross-cultural adaptation of the OARSI/OMERACT measure of intermittent and constant osteoarthritis pain (ICOAP). Osteoarthritis Cartilage 17(10):1293-6, 2009. e-Pub 2009. PMID: 19410033.
21. Aguilar-Chavez EA, Gamez-Nava JI, Lopez-Olivo MA, Galvan-Melendres S, Corona-Sanchez EG, Loaiza-Cardenas CA, Celis A, Cardona-Muñoz EG, Gonzalez-Lopez L. Circulating leptin and bone mineral density in rheumatoid arthritis. J Rheumatol 36(3):512-6, 2009. e-Pub 2009. PMID: 19208597.
22. Roundtree AK, Kallen MA, Lopez-Olivo MA, Kimmel B, Skidmore B, Ortiz Z, Cox V, Suarez-Almazor ME. Poor reporting of search strategy and conflict of interest in over 250 narrative and systematic reviews of two biologic agents in arthritis: a systematic review. J Clin Epidemiol 62(2):128-37, 2009. e-Pub 2008. PMID: 19013763.
23. Corona-Sanchez EG, Gonzalez-Lopez L, Muñoz-Valle JF, Vazquez-Del Mercado M, Lopez-Olivo MA, Aguilar-Chavez EA, Salazar-Paramo M, Loaiza-Cardenas C, Oregon-Romero E, Navarro-Hernandez RE, Gamez-Nava JI. Circulating e-selectin and tumor necrosis factor-alpha in extraarticular involvement and joint disease activity in rheumatoid arthritis. Rheumatol Int 29(3):281-6, 2009. e-Pub 2008. PMID: 18726101.
24. Lopez-Olivo MA, Kallen MA, Ortiz Z, Skidmore B, Suarez-Almazor ME. Quality appraisal of clinical practice guidelines and consensus statements on the use of biologic agents in rheumatoid arthritis: a systematic review. Arthritis Rheum 59(11):1625-38, 2008. PMID: 18975351.
25. Gonzalez-Lopez L, Sanchez-Hernandez JD, Aguilar-Chavez EA, Cota-Sanchez AR, Lopez-Olivo MA, Villa-Manzano AI, Ortega-Flores R, Espinoza-Magaña GL, Rojo-Contreras W, Cardona-Muñoz EG, Gamez-Nava JI. Hyperhomocysteinemia in ankylosing spondylitis: prevalence and association with clinical variables. Rheumatol Int 28(12):1223-8, 2008. e-Pub 2008. PMID: 18719918.
26. Gossec L, Jordan JM, Mazzuca SA, Lam MA, Suarez-Almazor ME, Renner JB, Lopez-Olivo MA, Hawker G, Dougados M, Maillefert JF, OARSI-OMERACT task force "total articular replacement as outcome measure in OA". Comparative evaluation of three semi-quantitative radiographic grading techniques for knee osteoarthritis in terms of validity and reproducibility in 1759 X-rays: report of the OARSI-OMERACT task force. Osteoarthritis Cartilage 16(7):742-8, 2008. e-Pub 2008. PMID: 18417373.
27. Villa-Manzano AI, Gamez-Nava JI, Salazar-Paramo M, Valera-Gonzalez IC, Garcia-Gonzalez A, Garcia-Gonzalez G, Morales-Romero J, Lopez-Olivo A, Galvan-Ramirez LM, Ruiz-Ruvalcaba R, Cardona-Muñoz EG, Gonzalez-Lopez L. Serum concentrations of aminoterminal propeptide of type III procollagen and propeptide of human type I procollagen in systemic lupus erythematosus. Rheumatol Int 26(8):712-6, 2006. e-Pub 2005. PMID: 16231121.
28. Lopez-Olivo MA, Gonzalez-Lopez L, Garcia-Gonzalez A, Villa-Manzano AI, Cota-Sanchez AR, Salazar-Paramo M, Varon-Villalpando E, Cardona-Muñoz EG, Gamez-Nava JI. Factors associated with hyperhomocysteinaemia in Mexican patients with rheumatoid arthritis. Scand J Rheumatol 35(2):112-6, 2006. PMID: 16641044.
29. Morales-Romero J, Cázares-Méndez JM, Gámez-Nava JI, Triano-Páez M, Villa-Manzano AI, López-Olivo MA, Rodríguez-Arreola BE, González-López L. [Patterns of health care in an out patient rheumatologic clinic]. Reumatol Clin 1(2):87-94, 2005. e-Pub 2008. PMID: 21794243.
30. He T, Lopez-Olivo MA, Hur C, Chhatwal J. Cost-Effectiveness of Direct-Acting Antivirals for Treatment of Hepatitis C Genotypes 2-6. Alimentary Pharmacology & Therapeutics.
31. des Bordes J, Suarez-Almazor ME, Volk RJ, Lu H, Edwards B, Lopez-Olivo MA. Development and testing of an educational website on promoting bone health in cancer survivors. J Health Comm.

Invited Articles

1. Tayar JH, Lopez-Olivo MA, Suarez-Almazor ME. Adalimumab: eight years of experience in rheumatoid arthritis. International Journal of Clinical Rheumatology 8(2):165-84, 2013.
2. Lopez-Olivo MA, Tayar JH. Safety concerns on the use of biologic drugs for the treatment of rheumatoid arthritis. CML Rhematology 31(4):101-16, 2012.
3. Lopez-Olivo MA, Suarez-Almazor ME. Developing guidelines in musculoskeletal disorders. Clin Exp Rheumatol 25(6 Suppl 47):28-36, 2007. PMID: 18021504.

Other Articles

1. Suarez-Almazor ME, Ortiz Z, Lopez-Olivo M, Moffett ML, Pak C, Skidmore B, Kimmel B, Kallen MA, Cox VL Long-term clinical and cost-effectiveness of infliximab and etanercept for rheumatoid arthritis. Canadian Agency for Drugs and Technologies in Health, 2007.
2. Suarez-Almazor ME, Ortiz Z, Lopez-Olivo M, Moffett ML, Pak C, Skidmore B, Kimmel B, Kallen MA, Cox VL Infliximab and etanercept in rheumatoid arthritis: systematic review of long-term clinical effectiveness, safety, and cost-effectiveness. Canadian Agency for Drugs and Technologies in Health, 2007.
3. Suarez-Almazor ME, Ortiz Z, Lopez-Olivo M, Pak C, Skidmore B, Kimmel B, Kallen MA, Cox VL, Roundtree A Infliximab and etanercept in rheumatoid arthritis: timing, dose escalation, and switching. Canadian Agency for Drugs and Technologies in Health, 2007.

Editorials

1. Lopez-Olivo MA, Tayar J, Suarez-Almazor ME. The updated guidelines on the use of rituximab in rheumatoid arthritis: Existing challenges and future opportunities. Rheumatology 50(12):2153-4, 2011.

Abstracts

1. Peddi P, Lopez-Olivo MA, Pratt G, Suarez-Almazor M. Denosumab in patients with cancer and skeletal metastases. Division of Internal Medicine Research Retreat, 2012.
2. Lopez-Olivo MA, Pratt G, Salahudeen A. Rasburicase for the treatment and prevention of tumor lysis sundrome in adults. Division of Internal Medicine Research Retreat, 2012.
3. Waimann CA, Fernandez-Mazarambroz RJ, Cantor S, Lopez-Olivo MA, Zhang H, Landon GC, Siff SJ, Suarez-Almazor ME. Impact of psychosocial determinants on total knee replacement (TKR) costs: results from the patient expectations about knee surgery (PEAKS) cohort. Arthritis Rheum 63(Suppl):S345, 2011.
4. Shah N, Pratt G, Suarez-Almazor M, Lopez-Olivo MA. Efficacy of bisphosphonates for bone metastases in patients with lung cancer: a systematic review and meta-analysis. Division of Internal Medicine Research Retreat, 2011.
5. Waimann CA, Fernandez-Mazarambroz RJ, Cantor S, Lopez-Olivo MA, Zhang H, Landon GC, Siff SJ, Suarez-Almazor ME. Impact of slow recovery and poor functional outcomes on direct and indirect costs after total knee replacement in osteoarthritis patients. Arthritis Rheum 63(Suppl):S347, 2011.
6. Lopez-Olivo MA, Tayar JH, Suarez-Almazor ME. Febuxostat for the treatment of chronic recurrent gout: a meta-analysis. Ann Rheum Dis 69(Suppl 3):608, 2010.
7. Lopez-Olivo MA, Suarez-Almazor ME, Shaw Y. A systematic review to appraise the quality of cost-effectiveness studies of biologic agents for the treatment of rheumatoid arthritis. Ann Rheum Dis 69(Suppl3):642, 2010.
8. Lopez-Olivo MA, Martinez-Lopez JA, Polo Cueto J, Pollono EN, Gonzalez-Crespo MR, Fulton S, Suarez-Almazor ME. Risk of malignancies in patients with rheumatoid arthritis treated with biologic therapy: meta-analysis of controlled trials. Division of Internal Medicine Research Retreat, 2010.
9. Marengo MF, Waimann CA, Lopez-Olivo MA, Looney C, Suarez-Almazor ME. Controversies in the use of acupuncture for osteoarthritis (OA): a systematic review of the quality and treatment features of randomized clinical trials (RCT). Arthritis Rheum 62(Suppl):S389-90, 2010.
10. Lopez-Olivo, MA, Shaw Y, Suarez-Almazor ME. A systematic review to appraise the quality of cost-effectiveness studies of biologic agents for the treatment of rheumatoid arthritis. Arthritis Rheum 62(Suppl):S315, 2010.
11. Lopez-Olivo MA, Kallen MA, Pak CH, Siff SJ, Landon GC, Edelstein D, Robinson KC, Suarez-Almazor ME. Using the patient generated index (PGI) to measure personalized quality of life (QoL) in patients undergoing total knee arthroplasty (TKA). Arthritis Rheum 62(Suppl):S74, 2010.
12. Lopez-Olivo MA, Martinez-Lopez JA, Tayar JH, Polo Cueto J, Pollono EN, Gonzales-Crespo MR, Fulton S, Suarez-Almazor ME. Risk of malignancies in patients with rheumatoid arthritis treated with biologic therapy: meta-analysis of controlled trials. Arthritis Rheum 62(Suppl):S171-2, 2010.
13. Lopez-Olivo MA, Kallen M, Pak C, Siff SJ, Landon GC, Edelstein D, Robinson KC, Zhang H, Suarez-Almazor ME. Psychosocial and educational barriers to surgical success after knee arthroplasty. Arthritis Rheum 60(Suppl 10), 2009.
14. Lopez-Olivo MA, Kallen MA, Pak C, Siff SJ, Landon GC, Edelstein D, Suarez-Almazor ME. Change of individual values among persons with total knee arthroplasty during the first six months of recovery, 2008.
15. Suarez-Almazor ME, Lopez-Olivo MA, Pak CH, Skidmore B. Long-term effectiveness during infliximab or etanercept therapy: A systematic review of observational studies. Arthritis Rheum 56(Suppl 9), 2007.
16. Lopez-Olivo MA, Andrabi TR, Suarez-Almazor ME. Cervical spine instability in patient with rheumatoid arthritis (RA) undergoing general surgery. Arthritis Rheum 56(Suppl 9), 2007.
17. Gossec L, Jordan JM, Mazzuca SM, Lam MA, Suarez-Almazor ME, Renner JB, Lopez-Olivo MA, Hawker G, Dougados M, Maillefert JF, Groupe de travail OARSI-OMERACT. La mesure de l’interligne articulaire est un meilleur indice structural dans la gonarthrose que les scores semi-quantitatifs : étude comparative de 3 méthodes d’évaluation de l’arthrose dans 1759 radiographies. French Rheumatology Society, 2007.
18. Lopez-Olivo MA, Kallen M, Ortíz Z, Kendall Roundtree A, Skidmore B, Suárez-Almazor M. Validez científica de las guías de práctica clínica sobre el uso del infliximab, etanercept y adalimumab en artritis reumatoide. VI Jornada Nacional de la Sociedad Argentina para la Calidad en Atención de la Salud, 2007.
19. Suarez-Almazor ME, Lopez-Olivo MA, Pak C, Ortiz Z, Cox VL, Skidmore B. Long-term effectiveness during infliximab or etanercept therapy: a systematic review of observational studies. Ann Rheum Dis 66(Suppl II):601, 2007.
20. Alcaraz-Lopez MF, Aguilar-Chavez EA, Sandoval-Ramirez L, Loaiza-Cardenas CA, Lopez-Olivo MA, Salazar-Paramo M, Davalos-Rodriguez IP, Martinez-Corral ME, Gamez-Nava JI , Gonzalez-Lopez L. Clinical, epidemiological factors and TAQI genotype of the vitamin D receptor in osteoporosis associated with rheumatoid arthritis. Ann Rheum Dis 66(Suppl II):591, 2007.
21. Lopez-Olivo MA, Roundtree AK, Ortiz Z, Skidmore B, Suarez-Almazor ME. Switching between anti-TNF agents treatments for rheumatoid arthritis: a systematic review. Ann Rheum Dis 66(Suppl II):189, 2007.
22. Gossec L, Jordan JM, Lam M, Suarez-Almazor ME, Mazzuca S, Renner JB, Lopez-Olivo, MA, Hawker G, Dougados M, Maillefert J. Measurement of joint space width appears to be the most valid indicator of structural damage in knee osteoarthritis: a comparative study of 3 radiographic scores in 1759 x-rays. Ann Rheum Dis 66(Suppl II):58, 2007.
23. Lopez-Olivo MA, Suarez-Almazor ME, Moffett ML. Economic evaluation of biologic therapies in ankylosing spondylitis: a systematic review. Ann Rheum Dis 66(Suppl II):274, 2007.
24. Gonzalez-Lopez L, Sanchez-Hernandez JD, Aguilar-Chavez EA, Villa-Manzano AI, Cota-Sánchez AR, Lopez-Olivo MA, Alonso-Gamiño L, Espinoza-Magaña GLC, Cardona-Muñoz EG, Rojo-Contreras EW, Gamez-Nava JI. Hyperhomocysteinemia in ankylosing spondylitis. Ann Rheum Dis 66(Suppl II):613, 2007.
25. Lopez-Olivo MA, Roundtree AK, Skidmore B, Suarez-Almazor ME. A systematic review on the occurrence of cancer in patients with rheumatoid arthritis while on treatment of anti-TNF-α agents. Division of Internal Medicine Research Retreat(Abstract C3), 2007.
26. Lopez-Olivo MA, Moffett MM, Kallen MA, Ortiz Z, Skidmore B, Suarez-Almazor ME. Economic evaluation of infliximab and etanercept: a systematic review. Ann Rheum Dis 65(Suppl II):329, 2007.
27. Lopez-Olivo MA, Kallen MA, Pak CH, Siff SJ, Landon GC, Eldestein D, Suarez-Almazor ME. Role of social support and depression on pain and function in patients undergoing total knee arthroplasty (TKA). Arthritis Rheum 56(Suppl 9), 2007.
28. Lopez-Olivo MA, Kallen MA, Richardson MN, Garcia-Gonzalez A, Cox VL, Lidsky M, Ng B, Marcus D, Reveille JD. Treatment adherence and use of reminders in patients with rheumatic disease. Arthritis Rheum 56(Suppl 9), 2007.
29. Lopez-Olivo MA, Kallen MA, Richardson MN, Garcia-Gonzalez A, Cox VL, Lidsky L, Ng B, Marcus D, Reveille JD. Effect of depression and social support on the self-reported adherence in patients with rheumatic diseases. Arthritis Rheum 56(Suppl 9), 2007.
30. Suarez-Almazor ME, Roundtree AK, Kallen MA, Lopez-Olivo MA, Ortiz Z, Skidmore B. Systematic review of reviews on the use of biologics for rheumatoid arthritis. Arthritis Rheum 56(Suppl 9), 2007.
31. Lopez-Olivo MA, Kallen MA, Ortiz Z, Roundtree AK, Skidmore B, Suarez-Almazor ME. Scientific validity of clinical practice guidelines for the use of infliximab and etanercept in rheumatoid arthritis. Arthritis Rheum 56(Suppl 9), 2007.
32. Lopez-Olivo MA, Ortiz Z, Pak CH, Cox V, Kimmel B, Kendall-Roundtree A, Skidmore B, Suarez-Almazor ME. A meta-analysis on the timing of therapeutic introduction of infliximab (ifx) and etanercept (etn). Ann Rheum Dis 65(Suppl II):329, 2006.
33. Gamez-Nava JI, Corona-Sanchez E, Aguilar-Chavez E, Muñoz-Valle J, Galvan-Melendez S, Loaiza-Cardenas C, Lopez-Olivo MA, Ortega-Flores R, Salazar-Paramo M, Rojo-Contreras E, Vazquez-Del Mercado M, Gonzalez-Lopez L. Serum-soluble e-selectin levels in active rheumatoid arthritis. Ann Rheum Dis 65(Suppl II):629, 2006.
34. Aguilar-Chavez EA, Gonzalez-Lopez L, Lopez-Olivo MA, Alcaraz-Lopez MF, Corona-Sanchez EG, Galvan-Melendez S, Loaiza-Cardenas C, Varón-Villalpando E, Rojo-Contreras EW, Gamez-Nava JI. Association between serum leptin levels and disease activity in rheumatoid arthritis. Ann Rheum Dis 65(Suppl II):628, 2006.
35. Suarez-Almazor, ME, Lopez-Olivo MA, Kendall-Roundtree A, Ortiz Z, Skidmore B. Dose escalation in anti-tnf therapy for rheumatoid arthritis (ra) a systematic review. Ann Rheum Dis 65(Suppl II):603, 2006.
36. Lopez-Olivo MA, Ortiz Z, Pak CH, Cox V, Kimmel B, Kendall-Roundtree A, Skidmore B, Suarez-Almazor ME. A meta-analysis on the timing of therapeutic introduction of infliximab (IFX) and etanercept (ETN). Arthritis Rheum 54(Suppl):S243-S243, 2006.
37. Lopez-Olivo MA, Moffett ML., Kallen MA., Ortiz Z., Skidmore B., Suarez-Almazor B.. Economic evaluation of infliximab and etarnercept: A sistematic review. Arthritis Rheum 54((9):Suppl):S336-S336, 2006.
38. Lopez-Olivo MA, Moffett ML, Cox VL, Richardson MN, Garcia-Gonzalez A, Suarez-Almazor ME. Association of SF-6D health utilities with activity and side effects in patients with systemic lupus erythematosus. Arthritis Rheum 54((9):Suppl):S335-S336, 2006.
39. Lopez-Olivo MA, Garcia-Gonzalez A, Kallen MA, Richardson MN, Cox VL, Janssen NM, Marcus DM, Reveille JD, Warner NB, Suarez-Almazor ME. Social support and quality of life in patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). Arthritis Rheum 54((9):Suppl):S335-S336, 2006.
40. Corona-Sanchez EG, Gonzalez-Lopez L, Ayala-Lopez K, Aguilar-Chavez EA, Munoz-Valle F, Galvan-Melendez S, Loaiza-Cardenas C, Lopez-Olivo MA, Ortega-Flores R, Salazar-Paramo M, Vazquez-Del Mercado M, Gamez-Nava JI. Levels of serum soluble E-selectin in active rheumatoid arthritis. Arthritis Rheum 54((9):Suppl):S379-S379, 2006.
41. Sanchez-Hernandez JD, Lopez-Olivo MA, Aguilar-Chavez E. Differences in the perception of health-related quality of life between men and women with ankylosing spondylitis. J Rheumatol 33((2):Suppl):408-408, 2006.
42. Alcaraz-Lopez MF, Gonzalez-Lopez L, Aguilar-Chavez E, Lopez-Olivo MA, Loaiza-Cardenas C, Gamez-Nava JI. Perfomance of Albrand index for identifying low bone density in rheumatoid arthritis. J Rheumatol 33((2):Suppl):408-409, 2006.
43. Aguilar-Chavez EA, Gonzalez-Lopez L, Lopez-Olivo MA, Galvan-Melendez S, Loaiza-Cardenas C, Alcaraz-Lopez MF, Gamez-Nava JI. Association between serum leptin levels and disease activity in rheumatoid arthritis. J Rheumatol 33((2):Suppl):409-409, 2006.
44. Lopez-Olivo MA, Garcia-Gonzalez A, Kallen MA, Richardson MN, Cox VL, Janssen NM, Marcus DM, Reveille JD, Warner NB, Suarez-Almazor ME. Social support and quality of life in patients with rheumatoid arthritis. J Rheumatol 33((2):Suppl):422-423, 2006.
45. Gamez-Nava, JI., Villa-Manzano, AI., Garcia-Gonzalez, A., Lopez-Olivo MA, Garcia-Gonzalez, G., Valera-Gonzalez, I., Salazar-Paramo, M., Morales-Romero, J., Gonzalez-Lopez, L.. Serum concentrations of aminoterminal propeptide of type III procollagen and propeptide of human type I procollagen in systemic lupus erythermatosus. Arthritis Rheum 48((9):Suppl):1487, 2003.
46. Lopez-Olivo MA, Gonzalez-Lopez L, Gámez-Nava JI, Salazar-Páramo M, García-González A, Villa-Manzano AI, Cota Sánchez AR.. Serum homocysteine levels in patients with rheumatoid arthritis. Rev. Mex. Reumatol 18(52), 2003.
47. Morales-Romero J, Lopez-Olivo MA, Villa-Manzano AI, García-González A, Hernandez-Romo JA, Gámez-Nava JI, Gonzalez-Lopez L.. Pain and perception of difficulty for the sexual relation: factors of risk for depression in rheumatoid arthritis. Rev. Mex. Reumatol 18(34), 2003.
48. Garcia-Gonzalez A, Villa-Manzano AI, Lopez-Olivo MA, Salazar-Páramo M, González-Valera I, Gámez-Nava JI, García-González G, Ornelas-Torres JC, Gonzalez-Lopez L, Cardona-Muñoz EG.. Comparison in serum levels of procollagen aminoterminal propeptides I and III in patients with systemic lupus erythematosus. Rev. Mex. Reumatol 18(29), 2003.
49. Romero Morales, J., Lopez Sandoval, I., Perez Serna JC, Lopez-Olivo MA, Villa Manzano, AI., Aguilar Chavez EAG., Gonzalez Lopez, L., Gamez Nava, JI.. Physician's behaviour regarding the use of alternative medicine in patients with rheumatoid arthritis. X Annual Meeting of the National Research Congress of Public Health, 2003.

Book Chapters

1. Suarez-Almazor ME, Lopez-Olivo MA, Ortiz Z.. Epidemiología clínica de las enfermedades reumáticas. In: Reumatologia: Argentina, 2010.
2. Lopez-Olivo MA, Suarez-Almazor ME. Esclerosis sistemica y epidemiologia. In: Esclerosis Sistemica: Mexico, 2009.
3. Lopez-Olivo MA, Suarez-Almazor ME. Evaluaciones económicas de los antagonistas del factor de necrosis tumoral alfa en la espondilitis anquilosante. In: Espondilitis anquilosante y otras espondiloartritis. Permanyer Publications: Spain, 2009.
4. Lopez-Olivo MA, Suarez-Almazor ME. Costo-efectividad de la terapia biologica en las enfemedades reumaticas. In: Teraia biologica en las enfermedades reumaticas. Doyma Masson Publications: Spain, 2006.

Letters to the Editor

1. Gonzalez-Lopez L, Lopez-Olivo MA, Gamez-Nava JI. Relationship between homocysteine and body mass index in rheumatoid arthritis [Authors’ Reply to]. Scand J Rheumatol 36: 243-4, 2007.